Get started
Author

Kisha K. Patel

Observed names: Kisha K Patel, Kisha Patel
ORCID: 0000-0002-0866-6195
Observed ORCID: 0000-0002-0866-6195
OpenAlex ID: A5085331050
In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
2020 · Stephany Y. Tzeng, Kisha K. Patel, et al. · Proceedings of the National Academy of Sciences · 52
The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function
2024 · Christopher M. Jackson, Ayush Pant, et al. · Immunity · 47
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
2021 · Kirit Singh, Kelly M. Hotchkiss, et al. · Cancers · 43
PDF
Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke
2023 · Jennifer E. Kim, Ryan P. Lee, et al. · Brain Behavior and Immunity · 37
Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery
2018 · Maziar Mohammadi, Kisha Patel, et al. · Acta Biomaterialia · 37
CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy
2024 · Ayush Pant, Brandon Hwa-Lin Bergsneider, et al. · OncoImmunology · 32
Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
2019 · James G Shamul, Sagar R Shah, et al. · International Journal of Nanomedicine · 31
PDF
The potential for immune checkpoint modulators in cerebrovascular injury and inflammation
2020 · Jennifer E. Kim, Kisha Patel, et al. · Expert Opinion on Therapeutic Targets · 29
The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2024 · Ayush Pant, Aanchal Jain, et al. · Cancer Immunology Research · 26
Absence of Ischemic Injury after Sacrificing the Superior Petrosal Vein during Microvascular Decompression
2019 · Yuanxuan Xia, Timothy Y Kim, et al. · Operative Neurosurgery · 18
Retrosigmoid approach for glycerin rhizotomy in the treatment of trigeminal neuralgia without overt arterial compression: updated case series
2019 · Timothy Y. Kim, Christopher M. Jackson, et al. · Journal of neurosurgery · 6
347 Cancer-associated Fibroblasts Affect GBM Progression
2022 · Timothy Y. Kim, Siddhartha Srivastava, et al. · Neurosurgery · 2
EXTH-68. Targeting Tumor Heterogeneity And Plasticity in Glioblastoma With Novel CAR T Cells Targeting PTPRZ1
2025 · ADITYA MOHAN, Barbara Lipes, et al. · Neuro-Oncology · 1
PDF
Data from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2024 · Ayush Pant, Aanchal Jain, et al. · 1
Immu-13. Efficacy of Cxcr6 Blockade as a Potentiator of Anti-pd-1 Therapy for the Treatment of Glioblastoma
2020 · Ayush Pant, Laura Saleh, et al. · Neuro-Oncology · 1
PDF
Ncog-32. the Safety and Efficacy of Dexamethasone in the Management of Glioma Patients
2020 · Ravi Medikonda, Kisha Patel, et al. · Neuro-Oncology · 1
PDF
106 Sacrificing the Superior Petrosal Vein During Microvascular Decompression Does Not Increase Vascular Complications
2018 · Yuanxuan Xia, Timothy Y Kim, et al. · Neurosurgery · 1
Figure S2 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S3 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S4 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S6 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S5 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S1 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Abstract 3193: Overcoming glioblastoma heterogeneity and plasticity through the development of novel chimeric antigen receptor (CAR)-T cells targeting PTPRZ1
2025 · Aditya A. Mohan, Barbara Lipes, et al. · Cancer Research
Figure S2 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2024 · Ayush Pant, Aanchal Jain, et al.
Works count: 33
Citation count: 364
H-index: 10
I10-index: 10
Year
Topic
Type